Circular RNAs as potential theranostics in the cardiac fibrosis

Area of Science:

• Molecular Biology
• Cardiovascular Research
• Genetics

Background:

• Circular RNAs (circRNAs) are non-coding RNA molecules with diverse biological roles.
• Cardiac fibrosis, a key factor in heart disease progression, is increasingly linked to circRNA dysregulation.
• Understanding circRNA involvement is crucial for cardiovascular disease research.

Purpose of the Study:

• To review the biogenesis and functions of circRNAs.
• To summarize recent findings on circRNAs in cardiac fibrosis pathogenesis.
• To explore the potential of circRNAs as biomarkers and therapeutic targets for heart disease.

Main Methods:

• Literature review of studies on circRNA biogenesis and function.
• Analysis of research linking circRNAs to cardiac fibrosis.
• Synthesis of current knowledge on circRNA-based diagnostics and therapeutics.

Main Results:

• CircRNAs play significant roles in cellular processes and disease development.
• Specific circRNAs are implicated in the occurrence and progression of cardiac fibrosis.
• Emerging evidence supports circRNAs as potential biomarkers and therapeutic targets.

Conclusions:

• CircRNAs are critical regulators in cardiovascular pathophysiology, particularly cardiac fibrosis.
• Further research into circRNAs offers promising avenues for novel diagnostic and therapeutic strategies in heart disease.